Lisata Therapeutics Statistics

Total Valuation

LSTA has a market cap or net worth of $18.16 million. The enterprise value is -$11.35 million.

Market Cap	18.16M
Enterprise Value	-11.35M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

LSTA has 8.41 million shares outstanding. The number of shares has increased by 3.17% in one year.

Current Share Class	8.41M
Shares Outstanding	8.41M
Shares Change (YoY)	+3.17%
Shares Change (QoQ)	+0.89%
Owned by Insiders (%)	19.94%
Owned by Institutions (%)	9.34%
Float	6.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.57
Forward PS	n/a
PB Ratio	0.67
P/TBV Ratio	0.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.16, with a Debt / Equity ratio of 0.00.

Current Ratio	6.16
Quick Ratio	5.89
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -51.77% and return on invested capital (ROIC) is -36.07%.

Return on Equity (ROE)	-51.77%
Return on Assets (ROA)	-31.23%
Return on Invested Capital (ROIC)	-36.07%
Return on Capital Employed (ROCE)	-76.25%
Revenue Per Employee	$38,462
Profits Per Employee	-$768,654
Employee Count	26
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	-798,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.67% in the last 52 weeks. The beta is 1.00, so LSTA's price volatility has been similar to the market average.

Beta (5Y)	1.00
52-Week Price Change	-26.67%
50-Day Moving Average	2.48
200-Day Moving Average	2.94
Relative Strength Index (RSI)	43.69
Average Volume (20 Days)	9,384

Short Selling Information

The latest short interest is 31,564, so 0.38% of the outstanding shares have been sold short.

Short Interest	31,564
Short Previous Month	40,079
Short % of Shares Out	0.38%
Short % of Float	0.47%
Short Ratio (days to cover)	1.82

Income Statement

In the last 12 months, LSTA had revenue of $1.00 million and -$19.99 million in losses. Loss per share was -$2.40.

Revenue	1.00M
Gross Profit	1.00M
Operating Income	-22.41M
Pretax Income	-23.18M
Net Income	-19.99M
EBITDA	-22.24M
EBIT	-22.41M
Loss Per Share	-$2.40

Full Income Statement

Balance Sheet

The company has $31.25 million in cash and $137,000 in debt, giving a net cash position of $31.11 million or $3.70 per share.

Cash & Cash Equivalents	31.25M
Total Debt	137,000
Net Cash	31.11M
Net Cash Per Share	$3.70
Equity (Book Value)	29.32M
Book Value Per Share	3.52
Working Capital	28.97M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-19.36M
Capital Expenditures	n/a
Free Cash Flow	-19.36M
FCF Per Share	-$2.30

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-2,240.90%
Pretax Margin	-2,078.30%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LSTA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.17%
Shareholder Yield	-3.17%
Earnings Yield	-101.13%
FCF Yield	-97.95%

Analyst Forecast

The average price target for LSTA is $15.00, which is 594.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	594.44%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	115.91%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on September 15, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Sep 15, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

LSTA has an Altman Z-Score of -20.38 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-20.38
Piotroski F-Score	1